• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度人的冠状动脉疾病流行:一个值得警惕并呼吁采取行动的问题。

Coronary artery disease epidemic in Indians: a cause for alarm and call for action.

作者信息

Enas E A

机构信息

Coronary Artery Disease in Asian Indians Research, Lisle, IL, USA.

出版信息

J Indian Med Assoc. 2000 Nov;98(11):694-5, 697-702.

PMID:11265799
Abstract

Coronary artery disease (CAD) rates in urban areas in India are now 4-fold higher than in the United States (US) although the rates were similar in 1968. Both overseas and resident Indians have the highest rates of CAD, although almost half of them are life-long vegetarians. When compared to Whites, Blacks, Hispanics and other Asians, CAD rates among Indians worldwide are two to four times higher at all ages and five to ten times higher in those < 40 years of age. Although CAD is a fatal disease with no known cure, it is also highly predictable, preventable, and treatable. During the past 30 years, CAD rates halved in the US, Australia, Canada, France, Japan, and Finland. These vast reductions in CAD mortality are attributed to nationwide changes in specific risk factors that were identified through epidemiological research and addressed through population-based interventions, rather than extensive use of expensive technology. Reduction in risk factors explains most of the decline with modest contributions from advances in treatment. Ironically, the CAD rates doubled in India during the same period, primarily due to dietary changes associated with epidemiological transition from a rural sustenance economy to an urban market oriented economy. The impact of such changes appears to be greater in Indians than in other populations due to a genetic predisposition. Significant decline of CAD is readily achievable in India, by adopting a combined population-wide and high-risk primary prevention strategy. This requires concerted action by the medical profession, govemment, media, and the public.

摘要

印度城市地区的冠状动脉疾病(CAD)发病率如今比美国高出4倍,尽管在1968年两者发病率相似。海外印度人和印度本土居民的CAD发病率最高,尽管他们中近一半是终身素食者。与白人、黑人、西班牙裔和其他亚洲人相比,全球范围内印度人的CAD发病率在各年龄段都高出两到四倍,在40岁以下人群中则高出五到十倍。尽管CAD是一种无法治愈的致命疾病,但它也是高度可预测、可预防和可治疗的。在过去30年里,美国、澳大利亚、加拿大、法国、日本和芬兰的CAD发病率减半。CAD死亡率的大幅下降归因于通过流行病学研究确定并通过基于人群的干预措施加以解决的特定风险因素在全国范围内的变化,而非昂贵技术的广泛使用。风险因素的降低解释了大部分下降情况,治疗进展的贡献较小。具有讽刺意味的是,同期印度的CAD发病率翻了一番,主要是由于从农村自给经济向城市市场经济的流行病学转变所带来的饮食变化。由于遗传易感性,这些变化对印度人的影响似乎比对其他人群更大。通过采取全面的人群预防和高危人群一级预防相结合的策略,印度很容易实现CAD发病率的显著下降。这需要医疗行业、政府、媒体和公众的共同行动。

相似文献

1
Coronary artery disease epidemic in Indians: a cause for alarm and call for action.印度人的冠状动脉疾病流行:一个值得警惕并呼吁采取行动的问题。
J Indian Med Assoc. 2000 Nov;98(11):694-5, 697-702.
2
Reducing the burden of coronary artery disease in India: challenges and opportunities.减轻印度冠状动脉疾病负担:挑战与机遇
Indian Heart J. 2008 Mar-Apr;60(2):161-75.
3
Coronary Artery Disease in Asian Indians: Prevalence and Risk Factors.亚洲印度人的冠状动脉疾病:患病率及风险因素
Asian Am Pac Isl J Health. 1993 Autumn;1(2):163-175.
4
The epidemiologic basis for population-wide cholesterol reduction in the primary prevention of coronary artery disease.在冠状动脉疾病一级预防中进行全人群胆固醇降低的流行病学依据。
Am J Cardiol. 2004 Nov 4;94(9A):4F-8F. doi: 10.1016/j.amjcard.2004.07.046.
5
Recent trends in coronary heart disease epidemiology in India.印度冠心病流行病学的近期趋势。
Indian Heart J. 2008 Mar-Apr;60(2 Suppl B):B4-18.
6
API expert consensus document on management of ischemic heart disease.缺血性心脏病管理的API专家共识文件
J Assoc Physicians India. 2006 Jun;54:469-80.
7
The promise and practice of cardiovascular risk reduction: a disease management perspective. Clinical Quality Improvement Network (CQIN) Investigators.心血管风险降低的前景与实践:疾病管理视角。临床质量改进网络(CQIN)研究人员。
Can J Cardiol. 1996 Oct;12(10):995-9.
8
Prevention of coronary heart disease among Indians: focus on primary prevention.印度人冠心病的预防:关注一级预防。
J Indian Med Assoc. 2000 Nov;98(11):703-4, 706-9.
9
Association of major modifiable risk factors among patients with coronary artery disease--a retrospective analysis.冠心病患者主要可改变危险因素的关联——一项回顾性分析
J Assoc Physicians India. 2004 Feb;52:103-8.
10
Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.幽门螺杆菌(H. pylori)感染与冠状动脉疾病:经皮冠状动脉腔内血管成形术后幽门螺杆菌根除对冠状动脉管腔的影响。人冠状动脉粥样硬化斑块中幽门螺杆菌特异性DNA的检测。
J Physiol Pharmacol. 2001 Aug;52(1 Suppl 1):3-31.

引用本文的文献

1
Profile of type 2 diabetes mellitus patients attending family medicine clinic in a rural tribal locality in India.印度农村部落地区家庭医学诊所2型糖尿病患者概况。
J Family Med Prim Care. 2023 Dec;12(12):3242-3248. doi: 10.4103/jfmpc.jfmpc_2114_22. Epub 2023 Dec 21.
2
Lipids in South Asians: Epidemiology and Management.南亚人的脂质情况:流行病学与管理
Curr Cardiovasc Risk Rep. 2019 Aug;13(8). doi: 10.1007/s12170-019-0618-9. Epub 2019 Jul 11.
3
Prevalence of type 2 diabetes mellitus and association of HbA1c with severity of coronary artery disease in patients presenting as non-diabetic acute coronary syndrome.
以非糖尿病急性冠状动脉综合征就诊患者的2型糖尿病患病率及糖化血红蛋白与冠状动脉疾病严重程度的关联
Egypt Heart J. 2020 Sep 29;72(1):66. doi: 10.1186/s43044-020-00101-0.
4
Lipoprotein(a): An underrecognized genetic risk factor for malignant coronary artery disease in young Indians.脂蛋白(a):印度年轻人群中未被充分认识的恶性冠状动脉疾病遗传危险因素。
Indian Heart J. 2019 May-Jun;71(3):184-198. doi: 10.1016/j.ihj.2019.04.007. Epub 2019 May 2.
5
Plasma lipid abnormalities in Pakistani population: trends, associated factors, and clinical implications.巴基斯坦人群中的血浆脂质异常:趋势、相关因素及临床意义。
Braz J Med Biol Res. 2018 Jul 23;51(9):e7239. doi: 10.1590/1414-431X20187239.
6
South Asian Cardiovascular Disease & Cancer Risk: Genetics & Pathophysiology.南亚心血管疾病和癌症风险:遗传学和病理生理学。
J Community Health. 2018 Dec;43(6):1100-1114. doi: 10.1007/s10900-018-0527-8.
7
Do practice gaps exist in evidence-based medication prescription at hospital discharge in patients undergoing coronary artery bypass surgery & coronary angioplasty?在接受冠状动脉旁路移植术和冠状动脉成形术的患者出院时,基于证据的药物处方是否存在实践差距?
Indian J Med Res. 2017 Dec;146(6):722-729. doi: 10.4103/ijmr.IJMR_1905_15.
8
Clinico-angiographic profile and procedural outcomes in patients undergoing percutaneous coronary interventions: The Srinagar registry.接受经皮冠状动脉介入治疗患者的临床血管造影特征及手术结果:斯利那加登记研究
Indian Heart J. 2017 Sep-Oct;69(5):589-596. doi: 10.1016/j.ihj.2017.01.021. Epub 2017 Feb 6.
9
Coronary artery disease in women.女性冠状动脉疾病
Indian Heart J. 2017 Jul-Aug;69(4):532-538. doi: 10.1016/j.ihj.2017.05.023. Epub 2017 Jun 12.
10
Recent trends in epidemiology of dyslipidemias in India.印度血脂异常的流行病学最新趋势。
Indian Heart J. 2017 May-Jun;69(3):382-392. doi: 10.1016/j.ihj.2017.02.020. Epub 2017 Mar 6.